Compare Halozyme Therapeutics Inc. Common Stock (HALO) vs Sempra Energy (SRE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Halozyme Therapeutics Inc. Common Stock vs Sempra Energy — how do they compare? Halozyme Therapeutics Inc. Common Stock trades at $110.59 (market cap $12.58B), while Sempra Energy trades at $81.32 (market cap $52.36B). The key difference: Sempra Energy is far larger — about 4.2× Halozyme Therapeutics Inc. Common Stock's market cap, and Sempra Energy pays a 3.28% dividend while Halozyme Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Halozyme Therapeutics Inc. Common Stock for 1 Days and Sempra Energy for 9 Days on average.
| HALO | SRE | |
|---|---|---|
Market Cap | $12.58B | $52.36B |
Volume | 2,179,278 | 3,338,383 |
Sector | Health | Utilities |
52-Week High | $115.22 | $99.75 |
52-Week Low | $61.63 | $76.90 |
Typical Hold Time | 1 Days | 9 Days |
Enterprise Value | $14.49B | $89.00B |
Dividend Yield | — | 3.28% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Halozyme Therapeutics Inc. Common Stock
Halozyme Therapeutics develops drug-delivery technologies for biopharmaceutical companies. Its ENHANZE technology uses the rHuPH20 enzyme to support subcutaneous delivery of co-administered medicines.
Read more on HALO →About Sempra Energy
Sempra is an energy infrastructure company with regulated utility and energy network businesses. Its operations include electric and gas utilities as well as energy infrastructure in North America.
Read more on SRE →
